CDRI

CDRI to work on major drugs, aims to cut healthcare costs

The Central Drug Research Institute (CDRI) will be working on around a dozen major drugs this year, targeting its goal of making affordable healthcare available to society. On National Science Day, the institute shared that the institute is working on Umifenovir for COVID-19, Picroliv for non-alcoholic fatty liver (NAFLD), Centinhale for drug-sensitive TB, S007-1500 for fracture healing and L-Ormeloxifene for contraception and that they are at different stages of clinical development.

More in CDRI

CSIR gets nod for Phase III trial of antiviral drug Umifenovir

"CSIR constituent lab CSIR-Central Drug Research Institute(CDRI) Lucknow, has received permission for carrying out Phase III randomised, Double-blind, Placebo-controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir," the Union Health Minister tweeted.
PM Narendra Modi visits CDRI complex

The institute organised an exhibition for the prime minister to highlight its contributions in drug discovery and development.
CDRI to introduce its 3 new drugs to PM during his visit

The institute is also organising an exhibition to highlight CDRI's contribution in the drug discovery and development for PM.
Herbal extracts holds promise to heal women bone fractures in 7 days flat !

The extracts have the potential to offer an alternative treatment to bone loss during osteoporosis, which is a 'porous bone' condition.
$herbal extracts holds promise to heal women bone fractures in 7 days flat$
National Family Planning Prog adds CDRI developed conceptive

A non-steroidal contraceptive pill developed by Central Drug Research Institute (CDRI) has been included in the National Family Planning Programme (NFPP).
Lucknow: CDRI makes drug from 'sheesham' leaves for bones

The city-based Central Drug Research Institute, a Council of Scientific and Industrial Research laboratory, has developed a new herbal medicine for bone health.